Drugs Made In America Acquisition II Corp. Unit (DMIIU) — Stock Valuation & Research

DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an existing business. The company specifically aims to acquire targets within the pharmaceutical and drug industries, driven by the goal of reducing the United States' reliance on international drug manufacturing. Each investment unit comprises one common stock share and an associated right, which entitles the holder to an additional one-tenth of a share once a suitable business combination is…

DMIIU key statistics

Price$10.25
Market cap$712.83M
SectorFinancial Services
IndustryShell Companies
ExchangeNASDAQ
52-week range9.935-10.8
Beta0.06

Explore DMIIU's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.